Last Updated: November 13, 2026

Nuvo Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NUVO PHARMS INC

NUVO PHARMS INC has ten approved drugs.

There are four US patents protecting NUVO PHARMS INC drugs.

Summary for Nuvo Pharms Inc

US Patents:	4
Tradenames:	9
Ingredients:	9
NDAs:	10

Drugs and US Patents for Nuvo Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nuvo Pharms Inc	NAPROXEN	naproxen	TABLET, DELAYED RELEASE;ORAL	091432-001	Sep 19, 2011	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	NAPROXEN	naproxen	TABLET, DELAYED RELEASE;ORAL	091432-002	Sep 19, 2011	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	PENNSAID	diclofenac sodium	SOLUTION;TOPICAL	020947-001	Nov 4, 2009		DISCN	Yes	No	8,741,956	⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	CAPSULE;ORAL	207118-001	Oct 28, 2016	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	TABLET;ORAL	207121-003	Mar 29, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	FOLIC ACID	folic acid	TABLET;ORAL	204418-001	Jul 28, 2015	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Nuvo Pharms Inc	SULFASALAZINE	sulfasalazine	TABLET, DELAYED RELEASE;ORAL	075339-001	Jan 11, 2002	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for NUVO PHARMS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	1.5%	➤ Subscribe	2012-07-11
➤ Subscribe	Topical Solution	2.0%	➤ Subscribe	2014-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.